Abstract
Real-time polymerase chain reaction (PCR) assays to detect antimicrobial resistance-associated mutations were tested on Neisseria gonorrhoeae-positive clinical samples with matched isolates. Of the nucleic acid amplification tests/cultures, 87.7% (64/73), 98.6% (72/73), and 98.4% (62/63) predicted cephalosporin, ciprofloxacin, and azithromycin susceptibilities, respectively. N. gonorrhoeae multiantigen sequence type was correctly predicted for 98.7% (79/80), and 13 of 58 N. gonorrhoeae-negative specimens showed false-positive results.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Azithromycin / pharmacology
-
Bacterial Typing Techniques
-
Cephalosporins / pharmacology
-
Ciprofloxacin / pharmacology
-
Drug Resistance, Bacterial / genetics*
-
False Positive Reactions
-
Gonorrhea / microbiology*
-
Humans
-
Microbial Sensitivity Tests
-
Multilocus Sequence Typing
-
Mutation
-
Neisseria gonorrhoeae / drug effects
-
Neisseria gonorrhoeae / genetics*
-
Real-Time Polymerase Chain Reaction
-
Sensitivity and Specificity
Substances
-
Anti-Bacterial Agents
-
Cephalosporins
-
Ciprofloxacin
-
Azithromycin